4th August 2021
Maven Capital Partners, one of the UK’s most active private equity houses, has invested a further £500,000 in GENinCode, a genetic testing company specialising in the risk assessment and prediction of cardiovascular disease. This funding package comes as the company completes its IPO, raising an additional £17 million gross and listing on AIM with a market capitalisation of £42.2 million.
12th July 2021
Maven Capital Partners has led the £2.6 million investment in cloud-based internal communication and employee engagement platform Oak Engage Limited. A total of £1.825 million has been provided by Maven’s Investor Partners network alongside a further £775,000 from the Maven managed North East Development Capital Fund and the North East Innovation Fund, supported by the European Regional Development Fund and managed by Northstar Ventures, as well as existing and new private investors.
2nd July 2021
Pembroke VCTthe venture capital trust focused on building the brands of tomorrow, has invested £1.75m into OnePlan, the collaborative, real-time platform providing a single source of truth for event planners worldwide. Pembroke is the lead investor in a total fundraise of £2.75m.
29th June 2021
UK-based agency Wooshii, which provides video content and software tools for blue-chip companies around the world, has received additional investment from YFM Equity Partners’ (YFM) managed funds to support its continued growth trajectory and further technology investment.
Founded by CEO, Fergus Dyer-Smith, over the last 10 years, Wooshii has reinvented the video production offering by giving clients the convenience and quality of a traditional production service with the additional benefits of a decentralised, global creative network, connected and enhanced by proprietary technology.
25th June 2021
YFM Equity Partners is continuing to support the growth of innovative Scottish software business Traveltek with a £1.3m investment from funds managed by YFM and co-investor FTI LLP.
23rd June 2021
Puma VCT 13 – the thirteenth Venture Capital Trust (VCT) launched by fund manager Puma Investments – has completed an attractive buyout of its stake in a fast-growing direct cremations business.
18th June 2021
Maven Capital Partners, one of the UK’s most active investors in growth businesses, has invested £2 million in London-based Guru Systems. Guru is a trusted supplier of B2B IoT hardware, software, and analytics solutions to energy companies, house builders, developers and housing associations looking to reduce their carbon footprint and operating costs, meet their regulatory obligations, and deliver the most efficient and cost-effective service to their own customers.
17th June 2021
NorthEdge has sold a majority stake in Orbis Protect, a leading provider of critical security services to the UK vacant property sector, to growth investor Synova to support its next phase of growth.
16th June 2021
Pembroke VCT, the venture capital trust focused on building the brands of tomorrow, has made an initial investment into COAT, the high-grade, sustainable paint company. COAT, which has been carbon-neutral since launch, is revolutionising the home decorating experience by redefining the customer experience of purchasing paint.
11th June 2021
YFM Equity Partners (YFM) has sold its stake in FourNet, the award-winning digital transformation and customer experience specialists whose clients include 10 Downing Street, the Cabinet Office, HM Treasury and the Bank of England. The secondary buyout deal backed by Palatine Private Equity generates a 6x return for YFM’s investors in less than four years.
9th June 2021
Private equity house YFM Equity Partners (YFM), which has offices in London, Birmingham, Leeds and Manchester, is continuing to Invest in its team with the promotion of Adam Hart to investment director.
7th June 2021
BGF, the UK & Ireland’s most active investor, has broken the £100 million investment milestone, backing more than 30 businesses across the fields of diagnostics, medtech and digital health, as well as services, software and tools supporting therapeutic development.